50 related articles for article (PubMed ID: 19725275)
1. Aggressiveness of inflammation in histological prostatitis--correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy.
Stimac G; Reljic A; Spajic B; Dimanovski J; Ruzic B; Ulamec M; Sonicki Z; Kraus O
Scott Med J; 2009 Aug; 54(3):8-12. PubMed ID: 19725275
[TBL] [Abstract][Full Text] [Related]
2. [Exploration and validation of optimal cut-off values for tPSA and fPSA/tPSA screening of prostate cancer at different ages].
Liu XM; Duan HY; Zhang DQ; Chen C; Ji YT; Zhang YM; Feng ZW; Liu Y; Li JJ; Zhang Y; Li CY; Zhang YC; Yang L; Lyu ZY; Song FF; Song FJ; Huang YB
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):354-364. PubMed ID: 38644271
[No Abstract] [Full Text] [Related]
3. PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience.
Merola R; Tomao L; Antenucci A; Sperduti I; Sentinelli S; Masi S; Mandoj C; Orlandi G; Papalia R; Guaglianone S; Costantini M; Cusumano G; Cigliana G; Ascenzi P; Gallucci M; Conti L
J Exp Clin Cancer Res; 2015 Feb; 34(1):15. PubMed ID: 25651917
[TBL] [Abstract][Full Text] [Related]
4. Associations of serum vitamin A and carotenoid levels with markers of prostate cancer detection among US men.
Beydoun HA; Shroff MR; Mohan R; Beydoun MA
Cancer Causes Control; 2011 Nov; 22(11):1483-95. PubMed ID: 21800039
[TBL] [Abstract][Full Text] [Related]
5. Interassay Variability and Clinical Implications of Five Different Prostate-specific Antigen Assays.
Kaufmann B; Pellegrino P; Zuluaga L; Ben-David R; Müntener M; Keller EX; Spanaus K; von Eckardstein A; Gorin MA; Poyet C
Eur Urol Open Sci; 2024 May; 63():4-12. PubMed ID: 38558765
[TBL] [Abstract][Full Text] [Related]
6. Elevation of Serum Prostate-Specific Antigen Levels in Males With Pulmonary Embolism.
Peng YF; Ma LY; Luo M
Clin Appl Thromb Hemost; 2024; 30():10760296241250002. PubMed ID: 38779806
[TBL] [Abstract][Full Text] [Related]
7. Associations of the Geriatric Nutritional Risk Index with high risk for prostate cancer: A cross-sectional study.
Miao S; Bao C; Zhang Y; Wang L; Jin X; Huang B; Zhang Z; Wang W
Nutrition; 2023 Nov; 115():112164. PubMed ID: 37573791
[TBL] [Abstract][Full Text] [Related]
8. A pilot study on percent free prostate specific antigen as an additional tool in prostate cancer screening.
Omar J; Jaafar Z; Abdullah MR
Malays J Med Sci; 2009 Jan; 16(1):44-7. PubMed ID: 22589648
[TBL] [Abstract][Full Text] [Related]
9. Incidence of histological prostatitis and its correlation with PSA density.
Piovesan AC; Freire Gde C; Torricelli FC; Cordeiro P; Yamada R; Srougi M
Clinics (Sao Paulo); 2009; 64(11):1049-51. PubMed ID: 19936177
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of the diagnostic accuracy of prostate specific antigen.
Harvey P; Basuita A; Endersby D; Curtis B; Iacovidou A; Walker M
BMC Urol; 2009 Sep; 9():14. PubMed ID: 19744336
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer incidence in men with self-reported prostatitis after 15 years of follow-up.
Vaarala MH; Mehik A; Ohtonen P; Hellström PA
Oncol Lett; 2016 Aug; 12(2):1149-1153. PubMed ID: 27446410
[TBL] [Abstract][Full Text] [Related]
12. Retracted: Exploration of the Value of Combined UA, IL-6, and fPSA/tPSA in the Diagnosis of Prostate Cancer.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9839167. PubMed ID: 38094390
[TBL] [Abstract][Full Text] [Related]
13. Effect of histological inflammation on total and free serum prostate-specific antigen values in patients without clinically detectable prostate cancer.
Stimac G; Spajic B; Reljic A; Katusic J; Popovic A; Grubisic I; Tomas D
Korean J Urol; 2014 Aug; 55(8):527-32. PubMed ID: 25132947
[TBL] [Abstract][Full Text] [Related]
14. Is there a correlation between the aggressiveness of chronic asymptomatic prostatitis National Institutes of Health category IV and the Gleason score in patients with prostate cancer?
Aglamis E; Ceylan C; Akin MM
Can Urol Assoc J; 2020 Nov; 14(11):E568-E573. PubMed ID: 32520704
[TBL] [Abstract][Full Text] [Related]
15. Telomeres and telomerase in prostate cancer development and therapy.
Graham MK; Meeker A
Nat Rev Urol; 2017 Oct; 14(10):607-619. PubMed ID: 28675175
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors?
Mischinger J; Comperat E; Schwentner C; Stenzl A; Gakis G
Curr Urol Rep; 2015 Sep; 16(9):59. PubMed ID: 26141938
[TBL] [Abstract][Full Text] [Related]
17. Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.
Umbehr MH; Gurel B; Murtola TJ; Sutcliffe S; Peskoe SB; Tangen CM; Goodman PJ; Thompson IM; Lippman SM; Lucia MS; Parnes HL; Drake CG; Nelson WG; De Marzo AM; Platz EA
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):264-9. PubMed ID: 25939516
[TBL] [Abstract][Full Text] [Related]
18. Infections and inflammation in prostate cancer.
Sfanos KS; Isaacs WB; De Marzo AM
Am J Clin Exp Urol; 2013 Dec; 1(1):3-11. PubMed ID: 25110720
[TBL] [Abstract][Full Text] [Related]
19. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes.
Shinohara DB; Vaghasia AM; Yu SH; Mak TN; Brüggemann H; Nelson WG; De Marzo AM; Yegnasubramanian S; Sfanos KS
Prostate; 2013 Jun; 73(9):1007-15. PubMed ID: 23389852
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer.
Kryvenko ON; Jankowski M; Chitale DA; Tang D; Rundle A; Trudeau S; Rybicki BA
Mod Pathol; 2012 Jul; 25(7):1023-32. PubMed ID: 22460812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
